• +1-646-491-9876
    • +91-20-67278686

    Search

    Traumatic Brain Injury-Pipeline Review H2 2017

    Traumatic Brain Injury-Pipeline Review H2 2017

    • Report Code ID: RW0001881458
    • Category Life Sciences
    • No. of Pages 252
    • Publication Month Jul-17
    • Publisher Name Global Markets Direct
    Traumatic Brain Injury-Pipeline Review H2 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury-Pipeline Review H2 2017 provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.

    Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache dizziness nausea or vomiting mood changes fatigue or drowsiness difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.

    The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Phase III Phase II Phase I Preclinical and Discovery stages are 1 6 9 55 and 8 respectively. Similarly the Universities portfolio in Preclinical and Discovery stages comprises 10 and 1 molecules respectively.

    Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System) .
    - The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    Introduction 5
    Traumatic Brain Injury-Overview 6
    Traumatic Brain Injury-Therapeutics Development 7
    Traumatic Brain Injury-Therapeutics Assessment 19
    Traumatic Brain Injury-Companies Involved in Therapeutics Development 31
    Traumatic Brain Injury-Drug Profiles 52
    Traumatic Brain Injury-Dormant Projects 227
    Traumatic Brain Injury-Discontinued Products 230
    Traumatic Brain Injury-Product Development Milestones 231
    Appendix 242

    List of Tables

    Number of Products under Development for Traumatic Brain Injury H2 2017
    Number of Products under Development by Companies H2 2017
    Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017
    Number of Products under Development by Companies H2 2017 (Contd..2) H2 2017
    Number of Products under Development by Companies H2 2017 (Contd..3) H2 2017
    Number of Products under Development by Universities/Institutes H2 2017
    Products under Development by Companies H2 2017
    Products under Development by Companies H2 2017 (Contd..1) H2 2017
    Products under Development by Companies H2 2017 (Contd..2) H2 2017
    Products under Development by Companies H2 2017 (Contd..3) H2 2017
    Products under Development by Universities/Institutes H2 2017
    Number of Products by Stage and Target H2 2017
    Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017
    Number of Products by Stage and Target H2 2017 (Contd..2) H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017 (Contd..2) H2 2017
    Number of Products by Stage and Route of Administration H2 2017
    Number of Products by Stage and Molecule Type H2 2017
    Traumatic Brain Injury-Pipeline by ALSP Inc H2 2017
    Traumatic Brain Injury-Pipeline by Apollo Endosurgery Inc H2 2017
    Traumatic Brain Injury-Pipeline by Aptinyx Inc H2 2017
    Traumatic Brain Injury-Pipeline by Athersys Inc H2 2017
    Traumatic Brain Injury-Pipeline by Beech Tree Labs Inc H2 2017
    Traumatic Brain Injury-Pipeline by Biogen Inc H2 2017
    Traumatic Brain Injury-Pipeline by Cantex Pharmaceuticals Inc H2 2017
    Traumatic Brain Injury-Pipeline by Cognosci Inc H2 2017
    Traumatic Brain Injury-Pipeline by Eustralis Pharmaceuticals Ltd H2 2017
    Traumatic Brain Injury-Pipeline by Intellect Neurosciences Inc H2 2017
    Traumatic Brain Injury-Pipeline by International Stem Cell Corp H2 2017
    Traumatic Brain Injury-Pipeline by Ischemix Inc H2 2017
    Traumatic Brain Injury-Pipeline by JT Pharmaceuticals Inc H2 2017
    Traumatic Brain Injury-Pipeline by Karyopharm Therapeutics Inc H2 2017
    Traumatic Brain Injury-Pipeline by Kyorin Pharmaceutical Co Ltd H2 2017
    Traumatic Brain Injury-Pipeline by Levolta Pharmaceuticals Inc H2 2017
    Traumatic Brain Injury-Pipeline by Lixte Biotechnology Holdings Inc H2 2017
    Traumatic Brain Injury-Pipeline by MandalMed Inc H2 2017
    Traumatic Brain Injury-Pipeline by Mapreg SAS H2 2017
    Traumatic Brain Injury-Pipeline by Neuralstem Inc H2 2017
    Traumatic Brain Injury-Pipeline by Neuren Pharmaceuticals Ltd H2 2017
    Traumatic Brain Injury-Pipeline by Neurofx Inc H2 2017
    Traumatic Brain Injury-Pipeline by NeuroNascent Inc H2 2017
    Traumatic Brain Injury-Pipeline by NeuroVive Pharmaceutical AB H2 2017
    Traumatic Brain Injury-Pipeline by New World Laboratories Inc H2 2017
    Traumatic Brain Injury-Pipeline by NoNO Inc H2 2017
    Traumatic Brain Injury-Pipeline by NuvOx Pharma LLC H2 2017
    Traumatic Brain Injury-Pipeline by Omeros Corp H2 2017
    Traumatic Brain Injury-Pipeline by Oxeia Biopharmaceuticals Inc H2 2017
    Traumatic Brain Injury-Pipeline by Prevacus Inc H2 2017
    Traumatic Brain Injury-Pipeline by QR Pharma Inc H2 2017
    Traumatic Brain Injury-Pipeline by RegeneRx Biopharmaceuticals Inc H2 2017
    Traumatic Brain Injury-Pipeline by Rubicon Biotechnology Inc H2 2017
    Traumatic Brain Injury-Pipeline by Sage Therapeutics Inc H2 2017
    Traumatic Brain Injury-Pipeline by SanBio Inc H2 2017
    Traumatic Brain Injury-Pipeline by STATegics Inc H2 2017
    Traumatic Brain Injury-Pipeline by Stemedica Cell Technologies Inc H2 2017
    Traumatic Brain Injury-Pipeline by SynZyme Technologies LLC H2 2017
    Traumatic Brain Injury-Pipeline by Tetra Discovery Partners LLC H2 2017
    Traumatic Brain Injury-Pipeline by vasopharm GmbH H2 2017
    Traumatic Brain Injury-Pipeline by VG Life Sciences Inc H2 2017
    Traumatic Brain Injury-Dormant Projects H2 2017
    Traumatic Brain Injury-Dormant Projects H2 2017 (Contd..1) H2 2017
    Traumatic Brain Injury-Dormant Projects H2 2017 (Contd..2) H2 2017
    Traumatic Brain Injury-Discontinued Products H2 2017

    List of Figures

    Number of Products under Development for Traumatic Brain Injury H2 2017
    Number of Products under Development by Companies H2 2017
    Number of Products under Development by Universities/Institutes H2 2017
    Number of Products by Top 10 Targets H2 2017
    Number of Products by Stage and Top 10 Targets H2 2017
    Number of Products by Top 10 Mechanism of Actions H2 2017
    Number of Products by Stage and Top 10 Mechanism of Actions H2 2017
    Number of Products by Top 10 Routes of Administration H2 2017
    Number of Products by Stage and Top 10 Routes of Administration H2 2017
    Number of Products by Top 10 Molecule Types H2 2017
    Number of Products by Stage and Top 10 Molecule Types H2 2017
    ALSP Inc
    Apollo Endosurgery Inc
    Aptinyx Inc
    Athersys Inc
    Beech Tree Labs Inc
    Biogen Inc
    Cantex Pharmaceuticals Inc
    Cognosci Inc
    Eustralis Pharmaceuticals Ltd
    Intellect Neurosciences Inc
    International Stem Cell Corp
    Ischemix Inc
    JT Pharmaceuticals Inc
    Karyopharm Therapeutics Inc
    Kyorin Pharmaceutical Co Ltd
    Levolta Pharmaceuticals Inc
    Lixte Biotechnology Holdings Inc
    MandalMed Inc
    Mapreg SAS
    Neuralstem Inc
    Neuren Pharmaceuticals Ltd
    Neurofx Inc
    NeuroNascent Inc
    NeuroVive Pharmaceutical AB
    New World Laboratories Inc
    NoNO Inc
    NuvOx Pharma LLC
    Omeros Corp
    Oxeia Biopharmaceuticals Inc
    Prevacus Inc
    QR Pharma Inc
    RegeneRx Biopharmaceuticals Inc
    Rubicon Biotechnology Inc
    Sage Therapeutics Inc
    SanBio Inc
    STATegics Inc
    Stemedica Cell Technologies Inc
    SynZyme Technologies LLC
    Tetra Discovery Partners LLC
    vasopharm GmbH
    VG Life Sciences Inc

    Request for Sample

    Report Url https://www.reportsweb.com//traumatic-brain-injury-pipeline-review-h2-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//traumatic-brain-injury-pipeline-review-h2-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//traumatic-brain-injury-pipeline-review-h2-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments